[Cardio-oncology, why is it a new specialty ?] 2021

M Moonen, and M L Nguyen Trung, and M Deneye, and P Lancellotti
Service de Cardiologie, CHU Liège, Belgique.

Cardio-oncology is a new interdisciplinary specialty that has emerged over the past ten years. With the development of increasingly potent cancer therapies which improve cancer survival, but at the cost of cardiovascular toxicity, the demand for specialized cardio-oncology services has emerged. Also, cardiovascular diseases are more common and more serious in cancer patients than in the general population. Cardio-oncology focuses on the prevention, detection, monitoring, and treatment of cardiovascular diseases in cancer patients, mostly those occurring as a side effect of chemo- and radiotherapy.

UI MeSH Term Description Entries
D008495 Medical Oncology A subspecialty of internal medicine concerned with the study of neoplasms. Oncology, Medical,Clinical Oncology,Oncology, Clinical
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D002319 Cardiovascular System The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body. Circulatory System,Cardiovascular Systems,Circulatory Systems
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D064420 Drug-Related Side Effects and Adverse Reactions Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals. Drug-Related Side Effects and Adverse Reaction,Adverse Drug Event,Adverse Drug Reaction,Drug Side Effects,Drug Toxicity,Side Effects of Drugs,Toxicity, Drug,Adverse Drug Events,Adverse Drug Reactions,Drug Event, Adverse,Drug Events, Adverse,Drug Reaction, Adverse,Drug Reactions, Adverse,Drug Related Side Effects and Adverse Reaction,Drug Related Side Effects and Adverse Reactions,Drug Side Effect,Drug Toxicities,Effects, Drug Side,Reactions, Adverse Drug,Side Effect, Drug,Side Effects, Drug,Toxicities, Drug

Related Publications

M Moonen, and M L Nguyen Trung, and M Deneye, and P Lancellotti
June 2019, European heart journal,
M Moonen, and M L Nguyen Trung, and M Deneye, and P Lancellotti
March 2021, Revue medicale suisse,
M Moonen, and M L Nguyen Trung, and M Deneye, and P Lancellotti
March 2018, La Revue du praticien,
M Moonen, and M L Nguyen Trung, and M Deneye, and P Lancellotti
April 2024, European heart journal,
M Moonen, and M L Nguyen Trung, and M Deneye, and P Lancellotti
October 1974, Acta medica Scandinavica,
M Moonen, and M L Nguyen Trung, and M Deneye, and P Lancellotti
August 2021, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography,
M Moonen, and M L Nguyen Trung, and M Deneye, and P Lancellotti
February 1969, Lakartidningen,
M Moonen, and M L Nguyen Trung, and M Deneye, and P Lancellotti
September 1996, Cardiologia (Rome, Italy),
M Moonen, and M L Nguyen Trung, and M Deneye, and P Lancellotti
July 2018, Leukemia & lymphoma,
M Moonen, and M L Nguyen Trung, and M Deneye, and P Lancellotti
January 2018, Frontiers in cardiovascular medicine,
Copied contents to your clipboard!